As of 2026-03-25, the Intrinsic Value of Praxis Precision Medicines Inc (PRAX) is -54.45 USD. This PRAX valuation is based on the model Peter Lynch Fair Value. With the current market price of 294.65 USD, the upside of Praxis Precision Medicines Inc is -118.48%.
Based on its market price of 294.65 USD and our intrinsic valuation, Praxis Precision Medicines Inc (PRAX) is overvalued by 118.48%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -54.45 - -54.45 | -54.45 | -118.48% |
| P/E | (207.12) - (264.18) | (236.84) | -180.4% |
| DDM - Stable | (79.99) - (297.28) | (188.64) | -164.0% |
| DDM - Multi | (37.86) - (115.51) | (57.75) | -119.6% |
| Market Cap (mil) | 8,206.00 |
| Beta | 2.17 |
| Outstanding shares (mil) | 27.85 |
| Enterprise Value (mil) | 7,848.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.41% |
| Cost of Debt | 5.00% |
| WACC | 7.04% |